Cohort study on chronic intestinal diseases in Toulouse
Chronic Intestinal Pathologies Analytical Cohort at TouLouse
This study is trying to learn more about chronic gut diseases like inflammatory bowel diseases and irritable bowel syndrome by collecting samples and information from patients to help find better treatments.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 1 site (Toulouse) |
| Trial ID | NCT04896684 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients with inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), and those requiring digestive examinations for colorectal cancer screening. It aims to collect biological samples such as blood, serum, plasma, and tissues from colon biopsies or surgical samples, along with associated clinical data. The goal is to enhance understanding of the pathophysiology of these chronic conditions and to develop new biomarkers and therapeutic targets for improved management.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 years old who require endoscopic explorations for suspected IBS, IBD, or colorectal cancer.
Not a fit: Patients who have received antibiotics recently, are pregnant or breastfeeding, or are under 18 years old may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better diagnostic and therapeutic strategies for patients with chronic intestinal diseases.
How similar studies have performed: Other studies have shown promise in understanding chronic intestinal diseases through similar observational approaches, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient requiring endoscopic explorations for screening or follow-up in the context of a suspected IBS or IBD or colorectal cancer Or * Patient with IBD requiring surgical management * Patient over 18 years old * Patient able to read and understand the information leaflet * Patients who have given their consent to participate in the study * Patients affiliated to a social security system (including AME) Exclusion Criteria: * Patients who have received antibiotic treatments in the 10 days preceding endoscopic exploration * Pregnant or breastfeeding patients * Patients under 18 years old * Patients under guardianship or curatorship * Patients unable to sign a free and informed consent
Where this trial is running
Toulouse
- Rangueil University Hospital — Toulouse, France (Recruiting)
Study contacts
- Principal investigator: Barbara Bournet, MD, PhD — University Hospital, Toulouse
- Study coordinator: Barbara Bournet, MD, PhD
- Email: bournet.b@chu-toulouse.fr
- Phone: 5 61 32 32 35
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.